179 related articles for article (PubMed ID: 17187081)
41. Pharmacological antagonism of the incretin system protects against diet-induced obesity.
Svendsen B; Capozzi ME; Nui J; Hannou SA; Finan B; Naylor J; Ravn P; D'Alessio DA; Campbell JE
Mol Metab; 2020 Feb; 32():44-55. PubMed ID: 32029229
[TBL] [Abstract][Full Text] [Related]
42. Appetite Regulation: Hormones, Peptides, and Neurotransmitters and Their Role in Obesity.
Miller GD
Am J Lifestyle Med; 2019; 13(6):586-601. PubMed ID: 31662725
[TBL] [Abstract][Full Text] [Related]
43. Physiological roles of the GIP receptor in murine brown adipose tissue.
Beaudry JL; Kaur KD; Varin EM; Baggio LL; Cao X; Mulvihill EE; Bates HE; Campbell JE; Drucker DJ
Mol Metab; 2019 Oct; 28():14-25. PubMed ID: 31451430
[TBL] [Abstract][Full Text] [Related]
44. Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats.
Baldassano S; Gasbjerg LS; Kizilkaya HS; Rosenkilde MM; Holst JJ; Hartmann B
Front Endocrinol (Lausanne); 2019; 10():492. PubMed ID: 31447774
[TBL] [Abstract][Full Text] [Related]
45. Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake.
Adriaenssens AE; Biggs EK; Darwish T; Tadross J; Sukthankar T; Girish M; Polex-Wolf J; Lam BY; Zvetkova I; Pan W; Chiarugi D; Yeo GSH; Blouet C; Gribble FM; Reimann F
Cell Metab; 2019 Nov; 30(5):987-996.e6. PubMed ID: 31447324
[TBL] [Abstract][Full Text] [Related]
46. Gut-derived GIP activates central Rap1 to impair neural leptin sensitivity during overnutrition.
Kaneko K; Fu Y; Lin HY; Cordonier EL; Mo Q; Gao Y; Yao T; Naylor J; Howard V; Saito K; Xu P; Chen SS; Chen MH; Xu Y; Williams KW; Ravn P; Fukuda M
J Clin Invest; 2019 Aug; 129(9):3786-3791. PubMed ID: 31403469
[TBL] [Abstract][Full Text] [Related]
47. Incretins in obesity and diabetes.
Chia CW; Egan JM
Ann N Y Acad Sci; 2020 Feb; 1461(1):104-126. PubMed ID: 31392745
[TBL] [Abstract][Full Text] [Related]
48. Gastrointestinal hormones and regulation of gastric emptying.
Camilleri M
Curr Opin Endocrinol Diabetes Obes; 2019 Feb; 26(1):3-10. PubMed ID: 30418188
[TBL] [Abstract][Full Text] [Related]
49. Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes.
Capozzi ME; DiMarchi RD; Tschöp MH; Finan B; Campbell JE
Endocr Rev; 2018 Oct; 39(5):719-738. PubMed ID: 29905825
[TBL] [Abstract][Full Text] [Related]
50. Glucagon-like peptide-1 regulates brown adipose tissue thermogenesis via the gut-brain axis in rats.
Krieger JP; Santos da Conceição EP; Sanchez-Watts G; Arnold M; Pettersen KG; Mohammed M; Modica S; Lossel P; Morrison SF; Madden CJ; Watts AG; Langhans W; Lee SJ
Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R708-R720. PubMed ID: 29847161
[TBL] [Abstract][Full Text] [Related]
51. Animal models of obesity and diabetes mellitus.
Kleinert M; Clemmensen C; Hofmann SM; Moore MC; Renner S; Woods SC; Huypens P; Beckers J; de Angelis MH; Schürmann A; Bakhti M; Klingenspor M; Heiman M; Cherrington AD; Ristow M; Lickert H; Wolf E; Havel PJ; Müller TD; Tschöp MH
Nat Rev Endocrinol; 2018 Mar; 14(3):140-162. PubMed ID: 29348476
[TBL] [Abstract][Full Text] [Related]
52. GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose.
Iwasaki Y; Sendo M; Dezaki K; Hira T; Sato T; Nakata M; Goswami C; Aoki R; Arai T; Kumari P; Hayakawa M; Masuda C; Okada T; Hara H; Drucker DJ; Yamada Y; Tokuda M; Yada T
Nat Commun; 2018 Jan; 9(1):113. PubMed ID: 29317623
[TBL] [Abstract][Full Text] [Related]
53. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
Turcot V; Lu Y; Highland HM; Schurmann C; Justice AE; Fine RS; Bradfield JP; Esko T; Giri A; Graff M; Guo X; Hendricks AE; Karaderi T; Lempradl A; Locke AE; Mahajan A; Marouli E; Sivapalaratnam S; Young KL; Alfred T; Feitosa MF; Masca NGD; Manning AK; Medina-Gomez C; Mudgal P; Ng MCY; Reiner AP; Vedantam S; Willems SM; Winkler TW; Abecasis G; Aben KK; Alam DS; Alharthi SE; Allison M; Amouyel P; Asselbergs FW; Auer PL; Balkau B; Bang LE; Barroso I; Bastarache L; Benn M; Bergmann S; Bielak LF; Blüher M; Boehnke M; Boeing H; Boerwinkle E; Böger CA; Bork-Jensen J; Bots ML; Bottinger EP; Bowden DW; Brandslund I; Breen G; Brilliant MH; Broer L; Brumat M; Burt AA; Butterworth AS; Campbell PT; Cappellani S; Carey DJ; Catamo E; Caulfield MJ; Chambers JC; Chasman DI; Chen YI; Chowdhury R; Christensen C; Chu AY; Cocca M; Collins FS; Cook JP; Corley J; Corominas Galbany J; Cox AJ; Crosslin DS; Cuellar-Partida G; D'Eustacchio A; Danesh J; Davies G; Bakker PIW; Groot MCH; Mutsert R; Deary IJ; Dedoussis G; Demerath EW; Heijer M; Hollander AI; Ruijter HM; Dennis JG; Denny JC; Di Angelantonio E; Drenos F; Du M; Dubé MP; Dunning AM; Easton DF; Edwards TL; Ellinghaus D; Ellinor PT; Elliott P; Evangelou E; Farmaki AE; Farooqi IS; Faul JD; Fauser S; Feng S; Ferrannini E; Ferrieres J; Florez JC; Ford I; Fornage M; Franco OH; Franke A; Franks PW; Friedrich N; Frikke-Schmidt R; Galesloot TE; Gan W; Gandin I; Gasparini P; Gibson J; Giedraitis V; Gjesing AP; Gordon-Larsen P; Gorski M; Grabe HJ; Grant SFA; Grarup N; Griffiths HL; Grove ML; Gudnason V; Gustafsson S; Haessler J; Hakonarson H; Hammerschlag AR; Hansen T; Harris KM; Harris TB; Hattersley AT; Have CT; Hayward C; He L; Heard-Costa NL; Heath AC; Heid IM; Helgeland Ø; Hernesniemi J; Hewitt AW; Holmen OL; Hovingh GK; Howson JMM; Hu Y; Huang PL; Huffman JE; Ikram MA; Ingelsson E; Jackson AU; Jansson JH; Jarvik GP; Jensen GB; Jia Y; Johansson S; Jørgensen ME; Jørgensen T; Jukema JW; Kahali B; Kahn RS; Kähönen M; Kamstrup PR; Kanoni S; Kaprio J; Karaleftheri M; Kardia SLR; Karpe F; Kathiresan S; Kee F; Kiemeney LA; Kim E; Kitajima H; Komulainen P; Kooner JS; Kooperberg C; Korhonen T; Kovacs P; Kuivaniemi H; Kutalik Z; Kuulasmaa K; Kuusisto J; Laakso M; Lakka TA; Lamparter D; Lange EM; Lange LA; Langenberg C; Larson EB; Lee NR; Lehtimäki T; Lewis CE; Li H; Li J; Li-Gao R; Lin H; Lin KH; Lin LA; Lin X; Lind L; Lindström J; Linneberg A; Liu CT; Liu DJ; Liu Y; Lo KS; Lophatananon A; Lotery AJ; Loukola A; Luan J; Lubitz SA; Lyytikäinen LP; Männistö S; Marenne G; Mazul AL; McCarthy MI; McKean-Cowdin R; Medland SE; Meidtner K; Milani L; Mistry V; Mitchell P; Mohlke KL; Moilanen L; Moitry M; Montgomery GW; Mook-Kanamori DO; Moore C; Mori TA; Morris AD; Morris AP; Müller-Nurasyid M; Munroe PB; Nalls MA; Narisu N; Nelson CP; Neville M; Nielsen SF; Nikus K; Njølstad PR; Nordestgaard BG; Nyholt DR; O'Connel JR; O'Donoghue ML; Olde Loohuis LM; Ophoff RA; Owen KR; Packard CJ; Padmanabhan S; Palmer CNA; Palmer ND; Pasterkamp G; Patel AP; Pattie A; Pedersen O; Peissig PL; Peloso GM; Pennell CE; Perola M; Perry JA; Perry JRB; Pers TH; Person TN; Peters A; Petersen ERB; Peyser PA; Pirie A; Polasek O; Polderman TJ; Puolijoki H; Raitakari OT; Rasheed A; Rauramaa R; Reilly DF; Renström F; Rheinberger M; Ridker PM; Rioux JD; Rivas MA; Roberts DJ; Robertson NR; Robino A; Rolandsson O; Rudan I; Ruth KS; Saleheen D; Salomaa V; Samani NJ; Sapkota Y; Sattar N; Schoen RE; Schreiner PJ; Schulze MB; Scott RA; Segura-Lepe MP; Shah SH; Sheu WH; Sim X; Slater AJ; Small KS; Smith AV; Southam L; Spector TD; Speliotes EK; Starr JM; Stefansson K; Steinthorsdottir V; Stirrups KE; Strauch K; Stringham HM; Stumvoll M; Sun L; Surendran P; Swift AJ; Tada H; Tansey KE; Tardif JC; Taylor KD; Teumer A; Thompson DJ; Thorleifsson G; Thorsteinsdottir U; Thuesen BH; Tönjes A; Tromp G; Trompet S; Tsafantakis E; Tuomilehto J; Tybjaerg-Hansen A; Tyrer JP; Uher R; Uitterlinden AG; Uusitupa M; Laan SW; Duijn CM; Leeuwen N; van Setten J; Vanhala M; Varbo A; Varga TV; Varma R; Velez Edwards DR; Vermeulen SH; Veronesi G; Vestergaard H; Vitart V; Vogt TF; Völker U; Vuckovic D; Wagenknecht LE; Walker M; Wallentin L; Wang F; Wang CA; Wang S; Wang Y; Ware EB; Wareham NJ; Warren HR; Waterworth DM; Wessel J; White HD; Willer CJ; Wilson JG; Witte DR; Wood AR; Wu Y; Yaghootkar H; Yao J; Yao P; Yerges-Armstrong LM; Young R; Zeggini E; Zhan X; Zhang W; Zhao JH; Zhao W; Zhao W; Zhou W; Zondervan KT; ; ; ; ; ; ; ; ; ; ; ; Rotter JI; Pospisilik JA; Rivadeneira F; Borecki IB; Deloukas P; Frayling TM; Lettre G; North KE; Lindgren CM; Hirschhorn JN; Loos RJF
Nat Genet; 2018 Jan; 50(1):26-41. PubMed ID: 29273807
[TBL] [Abstract][Full Text] [Related]
54. The Gastrointestinal Tract as an Integrator of Mechanical and Hormonal Response to Nutrient Ingestion.
Vella A; Camilleri M
Diabetes; 2017 Nov; 66(11):2729-2737. PubMed ID: 29061658
[TBL] [Abstract][Full Text] [Related]
55. Glucagon-like peptide-1 and glucose-dependent insulinotropic peptide: effects alone and in combination on insulin secretion and glucose disappearance in mice.
Pacini G; Ahrén B
Physiol Rep; 2017 Jun; 5(11):. PubMed ID: 28611149
[TBL] [Abstract][Full Text] [Related]
56. Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction.
Enoki Y; Watanabe H; Arake R; Fujimura R; Ishiodori K; Imafuku T; Nishida K; Sugimoto R; Nagao S; Miyamura S; Ishima Y; Tanaka M; Matsushita K; Komaba H; Fukagawa M; Otagiri M; Maruyama T
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):735-747. PubMed ID: 28608457
[TBL] [Abstract][Full Text] [Related]
57. Difference in protective effects of GIP and GLP-1 on endothelial cells according to cyclic adenosine monophosphate response.
Lim DM; Park KY; Hwang WM; Kim JY; Kim BJ
Exp Ther Med; 2017 May; 13(5):2558-2564. PubMed ID: 28565879
[TBL] [Abstract][Full Text] [Related]
58. TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD.
Musso G; Cipolla U; Cassader M; Pinach S; Saba F; De Michieli F; Paschetta E; Bongiovanni D; Framarin L; Leone N; Berrutti M; Rosina F; Corvisieri S; Molinaro F; Sircana A; Gambino R
J Lipid Res; 2017 Jun; 58(6):1221-1229. PubMed ID: 28242789
[TBL] [Abstract][Full Text] [Related]
59. Cardiovascular Benefits of Native GLP-1 and its Metabolites: An Indicator for GLP-1-Therapy Strategies.
Li J; Zheng J; Wang S; Lau HK; Fathi A; Wang Q
Front Physiol; 2017; 8():15. PubMed ID: 28194113
[TBL] [Abstract][Full Text] [Related]
60. The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice.
Burmeister MA; Ayala JE; Smouse H; Landivar-Rocha A; Brown JD; Drucker DJ; Stoffers DA; Sandoval DA; Seeley RJ; Ayala JE
Diabetes; 2017 Feb; 66(2):372-384. PubMed ID: 27908915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
